so im out of zlcs since the RS and i'm looking for a new long position. these are my concerns:
A) Financing. After the dilution, it seems oncs has enough resources to last throughout next year, is this correct? Prior to the refinancing it only had 7 million in cash (July 2013).
B) Should we anticipate further dilution?
C) Will an RS be necessary in the event of major market listing?
D) Long-term perspective. Months, years. More pullback?
Just wire me your money I will show you how to do it!
You are an idiot, and should not be investing. Do yourself the biggest favor, and let someone who knows something invest what little money you have left.
At this point, all you need to concern yourself with is trial results. There will be plenty of data released by the middle of next year which will indicate where this stock is headed
but is this the lowest point? will it remain at this price, or will we see a pullback to the teens? this is my concern. i want to go long on this stock, but biotech is so shady. i would hate to see an RS as well.